Archive for phase 1

Phase 1

This list gives a bit more detail about the phase 1 trials in progress. Typically, if there is an announcement of a drug successfully completing a trial, I will move it to the next stage before I see a press release or report saying that a new trial is starting. I assume it will move to the next stage.

[updated August 26, 2012]

Phase I Trials

1. Adrenocorticotrophic Hormone (ACTH, administered as Acthar Gel) (with interferon beta) (University of Southern California)

2. ARX-424 (pegylated version of interferon beta) (Merck Serono)

3. ATX-MS1467 (Apitope Technology / Merck Serono)

4. AZ01 (Interferon beta 1a – pegylated – bi-weekly or monthly injection) (Allozyne)

5. BaroFeron (aka NU100) (Nuron Biotech and BaroFold),cntnt01,detail,0&cntnt01articleid=2&cntnt01returnid=68

6. BIIB033 (aka Anti-Lingo) (Biogen)

7. CS-0777 (Daiichi-Sankyo)

8. ELND002 (Elan Pharmaceuticals)

9. Extended Release Formulation of IFNbeta-1a (Rebif) (Merck Serono)

10. GBR 500 (Glenmark Pharmaceuticals)

11. GSK1223249 (NOGO-A mAb) (GlaxoSmithKline)

12. GSK2018682 (sphingosine-1 phosphate receptor-1) (GlaxoSmithKline)

13. Lipoic acid (Oregon Health and Science University)

14. Low Fat Diet (Oregon Health and Science University)

15. Mesenchymal stem cell transplantation (autologous) (Cleveland Clinic)

16. Monoclonal antibody against MSRV/HERV-W (GeNeuro)

17. MOR103 (MorphoSys)

18. NI-0801 (NovImmune)

19. PDA-001 (aka cenplacel-L) (Celgene Cellular Therapeutics)

20. Peptide-coupled, peripheral blood mononuclear cells (Hamburg, Munich, Chicago)

21. Prolactin (aka NTx-488) (Stem Cell Therapeutics / University of Calgary),cntnt01,detail,0&cntnt01articleid=54&cntnt01detailtemplate=detail_currentProjects&cntnt01returnid=73&hl=eng

22. RGN-352 (RegeneRx)

23. RPC1063 (Receptos)

24. ShK-186 (Kineta)

25. TK54 (LTKfarma)

26. Valomaciclovir (EPB-348) (Epiphany Biosciences)

27. XP23829 (XenoPort)


Comments (1)